Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

80
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
80
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

160
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
160
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

67
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
67
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

55
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
55
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

91
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
91
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

74
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
74

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Framework for Risk-Based Implementation of Combination Therapy in CKD: Who, Why, When, and How?

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Physical Function Decline Among Adults With Moderate-to-Severe CKD.

Kidney international reports·2026
Same author

Modelled CKD Benefits of Broad Sodium-Glucose Cotransporter-2 Inhibitor Eligibility in the UK.

Kidney international reports·2026
Same author

Comparing Catheters to Fistulas in Older Patients Starting Hemodialysis (ACCESS HD).

Journal of the American Society of Nephrology : JASN·2026
Same author

Effects of Increasing the Concentration of Dialysate Magnesium on Cardiovascular Health: A Narrative Review.

Canadian journal of kidney health and disease·2026
Same author

Integrated, Community-Led, Culturally Safe Implementation of a Chronic Kidney Disease Detection Program for Indigenous Communities of Canada: The Kidney Check Program Report.

Canadian journal of kidney health and disease·2026

Related Experiment Video

Updated: Sep 11, 2025

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
05:53

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Published on: July 24, 2013

16.7K

Comparing Frailty Assessment Methods and Their Ability to Predict Adverse Outcomes in Patients with Advanced CKD.

Hailey V Hildebrand1,2, Oksana Harasemiw1,2, Ranveer Brar1,2

  • 1Chronic Disease Innovation Centre, Seven Oaks General Hospital, University of Manitoba, Winnipeg, Manitoba, Canada.

Clinical Journal of the American Society of Nephrology : CJASN
|August 13, 2025
PubMed
Summary
This summary is machine-generated.

Frailty assessment in advanced chronic kidney disease (CKD) using administrative data shows promise for identifying high-risk patients. Most administrative frailty measures predict adverse outcomes like mortality and hospitalization in CKD populations.

Keywords:
CKDmortality

More Related Videos

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
04:00

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles

Published on: July 26, 2024

664
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.4K

Related Experiment Videos

Last Updated: Sep 11, 2025

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
05:53

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Published on: July 24, 2013

16.7K
Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
04:00

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles

Published on: July 26, 2024

664
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.4K

Area of Science:

  • Nephrology
  • Gerontology
  • Public Health

Background:

  • Frailty is prevalent in chronic kidney disease (CKD) patients, increasing risks of disability, hospitalization, and mortality.
  • Clinical frailty assessment is resource-intensive; administrative data offers a potential alternative for efficient identification of at-risk individuals.
  • Identifying frail individuals in advanced, non-dialysis CKD is crucial for timely interventions.

Purpose of the Study:

  • To compare the agreement between administrative claims-based frailty definitions and objectively measured frailty in adults with advanced CKD.
  • To examine the association of these frailty definitions with adverse outcomes such as mortality and hospitalization.

Main Methods:

  • A cohort of advanced CKD participants from the Canadian Frailty Observation and Interventions Trial (CanFIT) in Manitoba was linked to administrative databases.
  • Frailty was assessed using objective measures (Fried Frailty Phenotype, SPPB, provider impression) and administrative data (Segal and modified pre-operative frailty indices).
  • Agreement between definitions and associations with adverse outcomes were analyzed.

Main Results:

  • The study included 442 participants with a mean age of 66 years; 58% were male.
  • Frailty prevalence varied significantly (19%-70%) based on the definition used.
  • Agreement between frailty definitions was poor (κ 0.09-0.33). Individuals identified as frail by most measures faced higher mortality and hospitalization risks, with an exception for the Segal Frailty Indicator.

Conclusions:

  • Most frailty assessment models, including administrative ones, effectively identify high-risk individuals with advanced non-dialysis CKD.
  • These findings support using administrative data for frailty screening to target interventions and improve patient outcomes.
  • Further research may refine administrative frailty measures for better accuracy in CKD populations.